Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Relatlimab |
Trade Name | |
Synonyms | BMS-986016 |
Drug Descriptions |
Relatlimab (BMS-986016) is a monoclonal antibody that targets LAG3 and inhibits binding of MHC II molecules to increase cytokine production by T-cells and prevent tumor growth (Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 9520-9520). |
DrugClasses | Immune Checkpoint Inhibitor 149 LAG3 Antibody 18 |
CAS Registry Number | 1673516-98-7 |
NCIT ID | C111999 |